New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Evogene Ltd.
EVGN
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

8M

Biotechnology

Next Earning date - 06 Mar 2025

8M

Biotechnology

Next Earning date - 06 Mar 2025

1.45USD

Shape-0.04 ( -2.36%)
sun-fogPre-market 1.46$arrow-right-up0.02 (1.38%)
Market Closed (as of Feb 05, 21:00 EDT)
favorite-chart

Relative Strenght

5
favorite-chart

Volume Buzz

-68%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

86%

Quote Panel

Shape
Updated February 7, 2025
1W 6.12 % 1M -6.02 % 3M -11.36 % 1Y -79.20 %

Key Metrics

Shape
  • Market Cap

    8.37M


  • Shares Outstanding

    5.37M


  • Share in Float

    5.28M


  • Dividende

    0


  • Earning Date

    06 Mar 2025


  • Price Target

    1.56


  • Average Volume

    66503


  • Beta

    1.084


  • Range

    1.2-10.4


  • Industry

    Biotechnology


  • Website

    https://www.evogene.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

EVGN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$15M

Shape713%

2025-Revenue

$3.11

Shape-137%

2025-EPS

$15M

Shape-212%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

JMP Securities

initialise

Previous: Not converted

2023-05-02

Now: Market Outperform

UBS

initialise

Previous: Not converted

2023-05-02

Now: Buy

Raymond James

initialise

Previous: Not converted

2023-05-02

Now: Strong Buy

Lake Street

initialise

Previous: Not converted

2023-05-02

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

N/A

-0.70
vs -1.80

Q1.23

arrow
arrow

N/A

-1.50
vs -2.00

Q2.23

arrow
arrow

N/A

-1.70
vs -2.10

Q3.23

arrow
arrow

N/A

-0.80
vs -1.60

Q4.23

arrow
arrow

N/A

-1.30
vs -0.70

Q1.24

arrow
arrow

N/A

-0.80
vs -1.50

Q2.24

arrow
arrow

N/A

-1.06
vs -1.70

Q3.24

arrow
arrow

N/A

-1.31
vs -0.80

Q4.24

arrow
arrow

N/A

-0.72
vs -1.30

Q1.25

arrow
arrow

N/A

-0.73
vs -0.80

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+112%

660K  vs 311K

Q1.23

arrow
arrow

+170%

641K  vs 237K

Q2.23

arrow
arrow

+110%

654K  vs 312K

Q3.23

arrow
arrow

+708%

3.8M  vs 466K

Q4.23

arrow
arrow

-12%

578K  vs 660K

Q1.24

arrow
arrow

+554%

4.2M  vs 641K

Q2.24

arrow
arrow

+40%

914K  vs 654K

Q3.24

arrow
arrow

-52%

1.8M  vs 3.8M

Q4.24

arrow
arrow

+527%

3.6M  vs 578K

Q1.25

arrow
arrow

-5%

4M  vs 4.2M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

-14%

-0.14
vs -0.23

Q1.23

arrow
arrow

-32%

-0.32
vs -0.14

Q2.23

arrow
arrow

-49%

-0.49
vs -0.32

Q3.23

arrow
arrow

-22%

-0.22
vs -0.49

Q4.23

arrow
arrow

-55%

-0.55
vs -0.22

Q1.24

arrow
arrow

-47%

-0.47
vs -0.55

Q2.24

arrow
arrow

-177%

-1.77
vs -0.47

Q3.24

arrow
arrow

+176%

1.76
vs -1.77

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

24

24
vs 28

-14%

Q4.22

arrow
arrow

28

28
vs 24

17%

Q1.23

arrow
arrow

26

26
vs 28

-7%

Q2.23

arrow
arrow

26

26
vs 26

NA

Q3.23

arrow
arrow

33

33
vs 26

27%

Q4.23

arrow
arrow

32

32
vs 33

-3%

Q1.24

arrow
arrow

28

28
vs 32

-12%

Q2.24

arrow
arrow

27

27
vs 28

-4%

Earnings Growth

Latest News